Prediction of the response of chronic hepatitis C to interferon alfa: A statistical analysis of pretreatment variables

Gut

Volumn 34, Issue 12, 1993, Pages 1714-1717

  Camps, J ^a   Crisostomo, S ^a   Garcia Granero, M ^a   Riezu Boj, J I ^a   Civeira, M P ^a   Prieto, J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHAN1 INTERFERON;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; CHRONIC DISEASE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C; HUMAN; INTERFERON-ALPHA; LIVER CIRRHOSIS; MALE; MIDDLE AGE; OBESITY; PLATELET COUNT; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0027385541     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.34.12.1714     Document Type: Article

References (27)

1. Davis, G.L.; Balart, L.A.; Schiff, E.R.; Lindsay, K.; Bodenheimer, H.C.; Perrillo, R.P. Treatment ofchronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial N EnglJ Med 1989 10.1056/NEJM198911303212203 321 1501
2. AM, Di Bisceglie; P, Martin; C, Kassianides; M, Lisker-Melman; L, Murray; J, Waggoner Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, doubleblind, placebo-controlled trial N Engl J Med 1989 10.1056/NEJM198911303212204 321 1506
3. Davis, G.L. Recombinant alfa-interferon treatment of non-A, non-B (type C) hepatitis: review of studies and recommendations for treatment Hepatol 1990 10.1016/0168-8278(90)90168-Q 11 72
4. Camps, J.; Castilla, A.; Ruiz, J.; Civeira, M.P.; Prieto, J. Randomised trial of lymphoblastoid alfa interferon in chronic hepatitis C: Effects on inflammation, fibrogenesis and viremia J Hepatol 1993 10.1016/S0168-8278(05)80223-5 17 390
5. Marcellin, P.; Boyer, N.; Giostra, E.; Degott, C.; Courouce, A.M.; Degos, F. Recombinant human alfa-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France Hepatology 1991 10.1002/hep.1840130302 13 393
6. Tine, F.; Magrin, S.; Craxi, A.; Pagliaro, L. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials J Hepatol 1991 10.1016/0168-8278(91)90814-R 13 192
7. Davis, G.L.; Lindsay, K.; Albrecht, J.; Bodenheimer, H.C.; Balart, L.A.; Perrillo, R.P. Predictors ofresponse to recombinant alpha interferon in patients with chronic hepatitis C Hepatology 1990 12 905
8. Causse, X.; Godinot, H.; Chevallier, M.; Chossegros, P.; Zoulim, F.; Ouzan, D. Comparison of 1 or 3 MU of interferon alfa2b and placebo in patients with chronic non-A, non-B hepatitis Gastroenterology 1991 10.1016/0016-5085(91)90030-O 101 497
9. Saracco, G.; Rosina, F.; Lattore, V.; Torrani-Cerenzia, M.R.; Chiandussi, L.; Gallo, V. Factors influencing long-term response of chronic non A, non B hepatitis to interferon treatment Hepatology 1990 12 437
10. Ideo, G.; Bellati, G.; Pedraglio, E.; Leandro, G. One year therapy of non-A, non-B/C chronic hepatitis with recombinant alpha2a interferon or lymphoblastoid alpha interferon J Hepatol 1990 2 3
11. Realdi, G.; Diodati, G.; Bonetti, P.; Scaccabarozzi, S.; Alberti, A.; Ruol, A. Recombinant human interferon alpha-2a in community-acquired non-A, non-B chronic hepatitis. Preliminary results of a randomized, controlled trial J Hepatol 1990 1 68
12. A, Di Bisceglie; JH, Hoofnagle Therapy of chronic hepatitis C with a-interferon: the answer? or more questions? Hepatology 1991 10.1002/hep.1840130332 13 601
13. Brook, M.G.; Karyiannis, P.; Thomas, H.C. Which patients with chronic hepatitis B virus infection will respond to ainterferon therapy? A statistical analysis of predictive factors Hepatology 1989 10.1002/hep.1840100502 10 761
14. Weck, P.K.; Leventhal, B.G.; Brand, C.; Finter, N. Detection and incidence of neutralizing antibodies to interferon-alpha-nI Interferon Res 1989 9 37 1
15. McCullough, A.J.; Stassen, W.N.; Wiesner, R.H.; Czaja, A.J. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity Hepatology 1987 10.1002/hep.1840070112 7 49
16. Jobson, J.D. Qualitative response regression models and logistic regression 1992 10.1007/978-1-4612-0921-8 278 Applied multivariate data analysis. Vol 2
17. Marcellin, P.; Giostra, E.; Boyer, N.; Loriot, M.-A.; MartinotPeignoux, M.; Benhamou, J.P. Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis? J Hepatol 1990 10.1016/0168-8278(90)90275-V 11 77
18. Shindo, M.; Di Bisceglie, A.M.; Cheung, L.; Shih, W.-K.; Cristiano, K.; Feinstone, S.M. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C Ann Intern Med 1991 10.7326/0003-4819-115-9-700 115 700
19. Angelico, M.; Gandin, C.; Goffredo, F.; Pescarmona, E.; Del Vecchio, C.; Capocaccia, L. A combination of interferon-alfa and ursodeoxycolic acid is more effective than interferonalfa alone in anti-HCV positive chronic hepatitis: a randomized, histology-controlled, clinical trial Gastroenterology 1992 102 775
20. Mazzella, G.; Salzetta, A.; Bazzoli, F.; Festi, D.; Aldini, R.; Morelli, C. Efficacy and factors predictive of response to treatment with lymphoblastoid interferon in chronic non-A, non-B hepatitis Gastroenterology 1992 102 661
21. Hassner, A.; Kletter, Y.; Shiag, D.; Yedvab, M.; Aronson, M.; Shibolet, S. Impaired monocyte function in liver cirrhosis BMJ 1981 10.1136/bmj.282.6272.1262 282 1262
22. Taylor, K.B.; Thomas, H.C. Gastrointestinal and liver diseases Appleton & Lange; clinical immunology 1987 468
23. Houghton, M.; Weiner, A.; Han, J.; Kuo, G.; Choo, Q.-L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease Hepatology 1991 10.1002/hep.1840140227 14 381
24. Okada, S.-I.; Akahane, Y.; Suzuki, H.; Okamoto, H.; Mishiro, S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients Hepatology 1992 10.1002/hep.1840160302 16 619
25. Martell, M.; Esteban, J.I.; Quer, J.; Genesca, J.; Weiner, A.; Esteban, R.; etal Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution J Virol 1992 10.1128/JVI.66.5.3225-3229.1992 66 3225
26. Kroon, C.; De Boer, A.; Kroon, J.M.; Schoenmaker, H.C.; Meer, F.J.M.; Cohen, A.F. Influence of skinfold thickness on heparin absorption Lancet 1991 10.1016/0140-6736(91)91573-D 337 945
27. Antonelli, G.; Currenti, M.; Turriziani, O.; Dianzani, F. Neutralizing antibodies to interferon-a: relative frequency in patients treated with different interferon preparations J Infect Dis 1991 10.1093/infdis/163.4.882 163 882